Molecular Therapy Journal Citation Rate 2026
1525-0016
eISSN 1525-0024
Elsevier BV
US
Q1 Quartile Top Tier
About Molecular Therapy
Molecular Therapy (MT) is a peer-reviewed academic journal covering CAR-T cell therapy research and CRISPR and Genetic Engineering, published by Elsevier BV in US, catalogued under ISSN 1525-0016 (e-ISSN 1525-0024). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 5.62 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3900 USD). OpenAlex records 22,906 works and 471,060 citations, with an h-index of 260.
Molecular Therapy Citation Rate 2026 — In Context
Molecular Therapy has a 2025 2-Year Citation Rate (OpenAlex) of 5.62, placing it in the Q1 quartile within the CAR-T cell therapy research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Molecular Therapy operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Molecular Therapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Molecular Therapy against similar journals in the field, use our journal comparison tool.
Submission Tips for Molecular Therapy
- Budget $3900 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers CAR-T cell therapy research, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Molecular Therapy Compares
Compared against 48 journals in the same research areas.
| ISSN (Print) | 1525-0016 |
|---|---|
| ISSN (Online) | 1525-0024 |
| Publisher | Elsevier BV |
| Country | United States |
| APC / Cost | $3900 USD |
In-depth profile & metrics
Molecular Therapy is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3900.
In our subject taxonomy, Molecular Therapy is classified under CAR-T cell therapy research, CRISPR and Genetic Engineering, RNA Interference and Gene Delivery and Viral Infectious Diseases and Gene Expression in Insects.
Molecular Therapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 5.617.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Molecular Therapy
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 5.617 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
CD2 costimulation breaks the CD28 vs. 4-1BB tradeoff in CAR T cells
Avery D. Posey • 2026
Compare Journals
Compare Molecular Therapy against similar publications in its field:
Related Journals in Your Field
-
Cancer Cell Elsevier IF 64.50
-
Experimental Cell Research Elsevier IF 64.50
-
Cell Research Springer Nature IF 64.50
-
Cell stem cell Elsevier IF 64.50
-
Advanced Drug Delivery Reviews Elsevier BV IF 12.22
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S51596929
Get weekly updates for CAR-T cell therapy research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.